Torrey Pines Law GroupFree Consultation
≡
  • About Us
    • About Our Firm
    • The Advantages of Hiring Our Firm
    • Recent Successes
    • Client Testimonials
    • Careers
    • Diversity, Equity & Inclusion
    • Locations
    • Boston
      • Boston Patent Atorneys
      • Boston FDA Regulatory Counsel
      • Boston Technology Transactions
    • Irvine
      • Irvine Patent Atorneys
      • Irvine FDA Regulatory Counsel
      • Irvine Technology Transactions
    • Los Angeles
      • Los Angeles Patent Atorneys
      • Los Angeles FDA Regulatory Counsel
      • Los Angeles Technology Transactions
    • San Diego
      • San Diego Patent Atorneys
      • San Diego FDA Regulatory Counsel
      • San Diego Technology Transactions
    • Contact
  • Professionals
    • Meet Our Team
    • Randy Berholtz, MLitt, MBA, JD
    • Robert Buchanan, PhD, JD
    • Kevin Buckley, JD
    • Frank Chen, PhD
    • Doranne Frano, MS, MBA
    • Dmitry Kryndushkin, PhD
    • Mark Malek, JD
    • James McFarland, JD
    • Eleanor Musick, JD
    • Shihong Nicolaou, PhD
    • Steven Stupp, PhD
    • Kyle Welch, JD
    • Fawn Zhang, PharmD, JD
    •  
    • Administration
    • Jaenna Barnard
    • Carina Collins
    • Amy Stedman
    • Cyndi Willis
    •  
    • Foreign Associates
  • Intellectual Property
    • Comprehensive IP Protection
    • Patent Preparation & Prosecution
    • ● Artificial Intelligence Patents
    • ● Biotechnology Patents
    • ● Chemistry Patents
    • ● Convergence Technology Patents
    • ● In Vitro Diagnostics Patents
    • ● Lasers & Optics Patents
    • ● Medical Device Patents
    • ● Pharmaceutical Patents
    • ● Pharmaceutical Lifecycle Management
    • ● Semiconductor Patents
    • ● Software Patents
    • ● Telecommunications Patents
    • ● Telemedicine Patents
    • National Phase Entry (PCT)
    • IP Litigation
    • IP Opinions & Counseling
    • IP Resources
      • Patent Rights Overview
      • International Patent Law
      • U.S. Patent Law
        • Patent Eligibility
        • Novelty
        • Obviousness
        • Written Description
        • Enablement
      • Anatomy of a U.S. Patent
        • Utility Patent
        • Design Patent
        • Plant Patent
      • Trademark Law
      • Copyright Law
      • Trade Secrets
      • Know How
      • Intangible Assets
  • Tech Transactions
    • International Technology Transactions
    • Corporate Strategy
    • Business Agreements
    • Transactional Due Diligence
    • Intellectual Property Agreements
    • Intellectual Property Due Diligence
    • Regulatory Agreements
    • Regulatory Due Diligence
  • FDA Regulatory
    • Global Strategic Counseling
    • Dossier Submissions
    • Quality Compliance (ISO)
    • CE Mark - MDR Services
    • Digital Health
    • Hatch-Waxman & Biosimilars
    • Labeling, Advertising & Promotion
    • Reimbursement & Health Economics
  • Experience
    • Our International Experience
    • Multinational Companies
    • Public Companies
    • Private Companies
    • Research & Academic Institutions
    • Hospitals & Physicians
    • Startups & Entrepreneurs
  • Contact
background
Hide
 
Show
  • background
  • torrey-pines-broken-hill
  • torrey-pines-sunset

Convergence Technology Patent Attorneys

Convergence Technology Patent Attorneys

Convergence Technology Law Firm having Offices in Boston, Los Angeles, Orange County, and San Diego

The term "convergence technology" is often defined in simplified terms as the combination of technologies from different fields into a single system or device. One general example is the "smart watch" which integrates telecommunications, information technology and biosensors into one system and device. Developments in other, more disparate technical fields are requiring both innovators and governments to adapt to new paradigms for protecting and regulating these novel combinations. Many examples of these technologies exist, such as :

  • AI-enabled systems which assist radiologists and pathologists with identifying tumors
  • Mobile wireless patient monitoring devices which provide continuous surveillance of vital signs
  • Contract Research Organizations and biopharmaceutical companies using artificial intelligence to improve and shorten clinical trial and drug development timelines
  • Algorithms that can help triage patients having and immediate need of attention, and which also improves hospital workflow

The impact of these convergence technologies was discussed at the 2020 World Medical Innovation Forum, at which Nobel Laureate and MIT professor Phil Sharp described convergence with an even broader vision:

"It’s not just computer science and biology that are converging, but engineering, physics, material science and agriculture too," he says.
“Life science is part of all of those processes and bringing physicists and engineering and information technology together to integrate life science with the translation to solving those problems is what convergence is about,” Sharp says. “It’ll be decades of exciting science and exciting technology.”

Our patent attorneys have represented clients with patenting convergence technology innovations for more than twenty years, and helped develop clinical and molecular pathology protocols for such convergent technologies as a scientist before becoming a patent attorney. Torrey Pines Law Group has assisted the combination of scientists, engineers, and physicians with developing, obtaining regulatory clearance, and commercializing convergence technologies including:

Drug Discovery and Design:

  • AI-enabled Drug Target Identification: Methods using AI to identify novel drug targets based on disease biology or protein structure analysis.
  • AI-enabled Lead Molecule Generation: Methods using AI to design and optimize potential drug candidates with desired properties.
  • Virtual Screening Techniques: AI-enabled virtual screening methods for identifying promising drug candidates from large chemical libraries.

Examples of drug development and optimization technologies include:

Drug Development and Optimization:

  • AI for Clinical Trial Design: Methods using AI to optimize clinical trial designs, including patient selection, dosage optimization, and predictive analytics.
  • AI-powered Drug Repositioning: Methods using AI to identify new therapeutic uses for existing drugs.
  • AI-based Pharmacokinetic and Pharmacodynamic Modeling: Methods using AI to predict drug behavior in the body, including absorption, distribution, metabolism, and excretion (ADME) and pharmacodynamic (PD) effects.

AI-integrated diagnostics and personalized medicine experience we have includes:

AI-integrated Diagnostics and Personalized Medicine:

  • AI-enabled Diagnostic Tools: AI-based algorithms for analyzing medical images, genetic data, or other biomarkers for disease diagnosis.
  • AI for Personalized Medicine Strategies: Methods using AI to personalize drug treatment plans based on individual patient characteristics.
  • AI-driven Companion Diagnostics: AI-enabled diagnostics used alongside specific drugs to identify patients most likely to benefit from treatment.

Other convergence technology experience we have includes:

Other Convergence Technologies:

  • AI-enabled Drug Manufacturing Processes: Methods using AI to optimize and automate drug manufacturing processes.
  • AI-integrated Drug Delivery Systems: Drug delivery systems with AI components for controlled release or personalized dosing.
  • Machine Learning for Electronic Health Record (EHR) Analysis: Methods using AI to analyze EHR data for drug discovery, adverse event detection, or personalized medicine applications.

We welcome the opportunity to see how we can work together. You can also find us on LinkedIn®, Yelp®, and Facebook®.

≡
  • Comprehensive IP Protection
  • Patent Preparation & Prosecution
  • ● Artificial Intelligence Patents
  • ● Biotechnology Patents
  • ● Chemistry Patents
  • ● Convergence Technology Patents
  • ● In Vitro Diagnostics Patents
  • ● Lasers & Optics Patents
  • ● Medical Device Patents
  • ● Pharmaceutical Patents
  • ● Pharmaceutical Lifecycle Management
  • ● Semiconductor Patents
  • ● Software Patents
  • ● Telecommunications Patents
  • ● Telemedicine Patents
  • National Phase Entry (PCT)
  • IP Litigation
  • IP Opinions & Counseling
  • IP Resources
    • Patent Rights Overview
    • International Patent Law
    • U.S. Patent Law
      • Patent Eligibility
      • Novelty
      • Obviousness
      • Written Description
      • Enablement
    • Anatomy of a U.S. Patent
      • Utility Patent
      • Design Patent
      • Plant Patent
    • Trademark Law
    • Copyright Law
    • Trade Secrets
    • Know How
    • Intangible Assets

Chambers Spotlight California 2025 Torrey Pines Law Group   Clio Reisman Award Torrey Pines Law Group COPYRIGHT © , TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.

Convergence Technology Patent Attorneys - Technological Convergence Patent Preparation & Prosecution Lawyer - Technology Convergence Intellectual Property Law Firm